Skip to Content
Skip to Content

Public activities coordination tool

Public activities coordination tool

The public activities coordination tool (PACT) provides an overview of the substance-specific activities that authorities are working on under REACH and the CLP Regulation. These activities are being carried out in line with ECHA’s Integrated Regulatory Strategy.

PACT provides up-to-date information on the activities planned, ongoing or completed by ECHA and/or MSCAs for a given substance in the following areas:

  • Data generation and assessment – dossier evaluation, substance evaluation, informal hazard assessment (PBT/vPvB/ED).
  • Regulatory management option analysis (RMOA).
  • Regulatory risk management – harmonised classification and labelling (CLH) , SVHC identification, restriction.

A summary of the all the substance-specific activities can be found under ‘Details’ for each entry.

resorcinol; 1,3-benzenediol

EC / List no: 203-585-2 CAS no: 108-46-3
Data generation and assessment
DEv - Dossier evaluation
DEv 1
Scope
Targeted
Status
Concluded
Decision date
Decision
Latest update
13/10/2018
More information View
SEv - Substance evaluation (Community Rolling Action Plan (CoRAP))
SEv 1
Evaluating Member State
Finland
Co-Evaluating Member State
Initial grounds for concern
Potential endocrine disruptor
Consumer use
High (aggregated) tonnage
Wide dispersive use
Year
2016
Status
Concluded
Conclusion document
Latest update
25/03/2020
More information View
SEv 2
Evaluating Member State
France
Co-Evaluating Member State
Initial grounds for concern
Potential endocrine disruptor
High (aggregated) tonnage
Year
2019
Status
Ongoing
Conclusion document
Latest update
23/03/2020
More information View
ED - Endocrine disruptor assessment
ED 1
Authority
France
Status
Under development
Outcome
Under development
Follow-up
No suggestion yet
Hazard assessment outcome document
Remarks
SVHC identification
Concern
Endocrine disruption
Date of intention
04/11/2019
Date of hazard assessment
Latest update
23/01/2020
More information View
ED 2
Authority
France
Status
Under development under SEV
Outcome
Under development under SEV
Follow-up
No suggestion yet
Hazard assessment outcome document
Remarks
Concern
Endocrine disruption
Date of intention
11/09/2018
Date of hazard assessment
Latest update
21/11/2019
More information View
ED 3
Authority
Finland
Status
Under development under SEV
Outcome
Under development under SEV
Follow-up
No suggestion yet
Hazard assessment outcome document
Remarks
Concern
Endocrine disruption
Date of intention
13/09/2016
Date of hazard assessment
Latest update
13/10/2016
More information View
Regulatory Management Option Analysis
RMOA 1
Authority
Finland
Concern
Endocrine disruption
Status
Concluded
Outcome
Appropriate to initiate regulatory risk management action
Follow-up
CLH
RMOA conclusion document
Remarks
Date of intention
29/08/2017
Date of RMOA conclusion
17/05/2018
Latest update
05/09/2019
More information View
Regulatory risk management
CLH - Harmonised classification and labelling
CLH 1
Status
Intention
Date of intention
31/12/2019
Withdrawal date
Submitter
Finland
Proposed harmonised classification by the dossier submitter
Acute Tox. 4, H302
Skin Irrit. 2, H315
Eye Irrit. 2, H319
Aquatic Acute 1, H400
Skin sensitisation
Remarks
Date of opinion
RAC Opinion
Latest update
03/02/2020
More information View
SVHC - Substances of very high concern
SVHC 1
Status
Intention
Date of intention
12/08/2019
Withdrawal date
Submitter
France
Remarks
Scope
Endocrine disrupting properties (Article 57(f) – human health)
Date of inclusion in Candidate List
Latest update
19/08/2019
More information View

Export search results to:

Categories Display

Tagged as:

(click the tag to search for relevant content)


Route: .live2